Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation
about
The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous diseaseRosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory ConditionTopical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea TreatmentsMajor pathophysiological correlations of rosacea: a complete clinical appraisalDysbiotic Bacterial and Fungal Communities Not Restricted to Clinically Affected Skin Sites in DandruffManagement of cutaneous rosacea: emphasis on new medical therapies.Structure and function of the human skin microbiomeThe bacteriology of hidradenitis suppurativa: a systematic review.Dermasence refining gel modulates pathogenetic factors of rosacea in vitro.An emerging treatment: Topical ivermectin for papulopustular rosacea.Human demodicosis: revisit and a proposed classification.Endoplasmic reticulum stress: key promoter of rosacea pathogenesis.Ivermectin: A Review in Rosacea.Inflammasomes and dermatology.Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.Association study of Demodex bacteria and facial dermatoses based on DGGE technique.The effect of skin moisture, pH, and temperature on the density of Demodex folliculorum and Demodex brevis (Acari: Demodicidae) in students and staff of the Erzincan University, Turkey.Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study.Characteristics of subjective recognition and computer-aided image analysis of facial erythematous skin diseases: a cornerstone of automated diagnosis.Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel.What if scalp flora was involved in sensitive scalp onset?Thickness of carotid intima and epicardial fat in rosacea: a cross-sectional study.Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.Afoxolaner and fluralaner treatment do not impact on cutaneous Demodex populations of healthy dogs.Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.Activation of Neutrophils via IP3 Pathway Following Exposure to Demodex-Associated Bacterial Proteins.Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study.Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea.Demodex and skin disease - false creation or palpable form?Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease?Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea.Demodex spp. as a possible aetiopathogenic factor of acne and relation with acne severity and type.
P2860
Q27005460-970DEDB0-E7AF-4565-8DE7-B3096B8ECA03Q28067747-9363C3AD-713F-40FC-8C08-658F5D9709CDQ28072685-61662FC7-F1DB-45FB-8311-4E805A3A3594Q28082171-E61698E6-013C-4212-84FC-3E9BCB8CF650Q28821271-3627BF7F-D5B6-4D9E-9143-7A6C9C971069Q34436744-3D2DC862-5971-4A47-96EE-EAB5617455C8Q35044638-3C906854-CCFD-46C4-9E78-C133820DC5AAQ35676683-129F9B63-D393-4013-AEE3-2BA0B0755B85Q36325038-A18A6466-E31F-4D79-BF9D-F57D691057A4Q37842875-505D2BAF-BAF7-43D8-A1FA-B9429F5F4F25Q38182648-10188C7F-E02C-4BED-8067-AB78FFBAB956Q38232251-14287EBE-93A1-4ED5-88D7-A38F8BD89CCDQ38562760-89F9549D-6C6D-4543-9BC2-E177405312DAQ38797090-900844D2-D18F-45A3-A9FB-0112018BF1E0Q38885566-25A41F1D-D95C-4DD3-B313-C0F259A24E75Q39034689-B45B5DC3-DCC5-43AC-AA3B-EEF345BF87F2Q39624814-C53C351F-E362-4B6F-BDB0-7BCA4BA3A029Q42368921-A46C8AD0-60C3-46F5-A680-DE207183D2A7Q44569857-5AE0F6BA-715C-4CCC-B6BD-B18AE7E32A39Q45153684-E475906F-E7D5-4C00-A1EA-B4F938BC14FDQ46626563-41D8E4E9-9585-41A7-8423-AB41C8AE37B3Q47549529-4BF17A98-7864-44BF-A6BF-7B973FD69E6EQ47558329-90C1C51C-9D0B-4D31-B78B-FB9AEB12DD4AQ48094664-ADA1594B-9F9F-4A24-A392-DEF121EA6A77Q50559237-43548EF5-B342-4085-B7CD-65F75924274DQ51587711-92C53F4A-80D1-43FE-A039-A5A2F35BF7A6Q52840663-3B2A7A6A-13DF-43A7-B973-9EC7D72379DCQ53519437-319DE024-84D3-4747-9D66-5F837F212FDAQ54343506-CE3A2736-6294-4FBD-9BE1-F95EE06C41CCQ55193902-5F0B5261-F072-4EF4-A491-D871471B7D52Q55340442-986AAAFC-B837-4AAC-8A55-03D4CE16EF55Q55425208-DC0A2950-B626-4821-865D-A703275583E2
P2860
Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Quantification of Demodex foll ...... skin innate immune activation
@ast
Quantification of Demodex foll ...... skin innate immune activation
@en
Quantification of Demodex foll ...... skin innate immune activation
@nl
type
label
Quantification of Demodex foll ...... skin innate immune activation
@ast
Quantification of Demodex foll ...... skin innate immune activation
@en
Quantification of Demodex foll ...... skin innate immune activation
@nl
prefLabel
Quantification of Demodex foll ...... skin innate immune activation
@ast
Quantification of Demodex foll ...... skin innate immune activation
@en
Quantification of Demodex foll ...... skin innate immune activation
@nl
P2093
P3181
P356
P1476
Quantification of Demodex foll ...... skin innate immune activation
@en
P2093
Anne M Schmitt
Arnaud Degouy
Bulai Livideanu
Carle Paul
Christiane Casas
Christine Saint-Martory
Daniel Redoulès
Elizabeth Durbise
Hervé Ginisty
Morad Lahfa
P304
P3181
P356
10.1111/EXD.12030
P407
P577
2012-12-01T00:00:00Z